In fiscal 2025, which ended Dec 31, 2025, Edap TMS SA used $16.4 million of cash from operations.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
|---|---|---|
| Operating | ||
| Depreciation and amortization |
—
|
3
|
| Operating cash flow |
—
|
-16
|
| Investing | ||
| Investing cash flow |
—
|
-6
|
| Financing | ||
| Debt issued |
—
|
12
|
| Debt repaid |
—
|
3
|
| Financing cash flow |
—
|
9
|
| Change in cash | ||
| Effect of exchange rate |
—
|
3
|
| Net change in cash |
—
|
-11
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- FOCL (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- 69120 Vaulx En Velin, France
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1041934
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.